Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tolerance and Efficacy Study of Second-line Surgery After Percutaneous Needle Aponeurotomy for Dupuytren's Disease. URAM 3

NCT04164953 is registered in ClinicalTrials.gov with GCS Ramsay Santé pour l'Enseignement et la Recherche as lead sponsor.

NCT NCT04164953
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04164953 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tolerance and Efficacy Study of Second-line Surgery After Percutaneous Needle Aponeurotomy for Dupuytren's Disease. URAM 3
Lead sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche
Phase
Not applicable
Overall status
Unknown status
Start date
April 12, 2019
Completion date
June 30, 2021
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dupuytren's disease, surgical incision